PSMB1 | Proteasome (prosome, macropain) subunit, beta type, 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/29635/64707_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
PSMB10 | Proteasome (prosome, macropain) subunit, beta type, 10 | Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30225/69734_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
PSMB2 | Proteasome (prosome, macropain) subunit, beta type, 2 | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/26322/ihc_selected_60x60.jpg) | | ![](/images/26324/ihc_cell_selected_60x60.jpg) | ![](/images/26322/56170_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
PSMB5 | Proteasome (prosome, macropain) subunit, beta type, 5 | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/49518/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49518/112212_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PSMB9 | Proteasome (prosome, macropain) subunit, beta type, 9 | Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/15180/142201_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/8356/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8356/25112_B_6_1_rna_selected_60x60.jpg) | Tissue enriched |
RFK | Riboflavin kinase | Enzymes FDA approved drug targets
| ![](/images/57163/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/57163/131876_B_3_8_rna_selected_60x60.jpg) | Expressed in all |
RRM1 | Ribonucleotide reductase M1 | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/22093/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/22093/58670_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
RRM2 | Ribonucleotide reductase M2 | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/56994/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/56994/128450_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
RRM2B | Ribonucleotide reductase M2 B (TP53 inducible) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/28812/ihc_selected_60x60.jpg) | | | ![](/images/6854/16395_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
SHMT1 | Serine hydroxymethyltransferase 1 (soluble) | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/23314/50752_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
SMOX | Spermine oxidase | Enzymes FDA approved drug targets
| ![](/images/47117/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/47117/105836_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
SMS | Spermine synthase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images/29852/ihc_cell_selected_60x60.jpg) | ![](/images/29849/65028_A_2_7_rna_selected_60x60.jpg) | Expressed in all |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | ![](/images/47171/146636_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
SRC | V-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| ![](/images/30875/ihc_selected_60x60.jpg) | | | ![](/images/4023/11916_B_8_2_rna_selected_60x60.jpg) | Mixed |
TBXAS1 | Thromboxane A synthase 1 (platelet) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/31259/67793_A_3_6_rna_selected_60x60.jpg) | Mixed |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | ![](/images/19039/43951_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
TOP1MT | Topoisomerase (DNA) I, mitochondrial | Enzymes FDA approved drug targets Mitochondrial proteins Predicted secreted proteins
| ![](/images/21542/ihc_selected_60x60.jpg) | | ![](/images/1915/ihc_cell_selected_60x60.jpg) | ![](/images/21542/48476_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/2448/6155_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/4601/11582_B_2_2_rna_selected_60x60.jpg) | Expressed in all |
TXNRD1 | Thioredoxin reductase 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/15834/34861_B_1_4_rna_selected_60x60.jpg) | Expressed in all |
YES1 | V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/26480/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26480/55497_B_9_1_rna_selected_60x60.jpg) | Expressed in all |